Nimesulide. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
about
Targeting KSHV/HHV-8 latency with COX-2 selective inhibitor nimesulide: a potential chemotherapeutic modality for primary effusion lymphomaNonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysisEffects of nimesulide on kainate-induced in vitro oxidative damage in rat brain homogenatesThe COX-2 inhibitors, meloxicam and nimesulide, suppress neurogenesis in the adult mouse brain.When to try COX-2-specific inhibitors. Safer than standard NSAIDs in some situations.Nimesulide: some pharmaceutical and pharmacological aspects--an update.Plasma and synovial fluid concentrations of nimesulide and its main metabolite after a single or repeated oral administration in patients with knee osteoarthritis.Calcium antagonistic properties of the cyclooxygenase-2 inhibitor nimesulide in human myometrial myocytes.Hyaluronic acid-nimesulide conjugates as anticancer drugs against CD44-overexpressing HT-29 colorectal cancer in vitro and in vivo.Practical approach to the treatment of NSAID hypersensitivity.Protective role ofPhyllanthus niruri against nimesulide induced hepatic damage.Physicochemical characterization and dissolution properties of nimesulide-cyclodextrin binary systems.Study of nimesulide release from solid pharmaceutical formulations in tween 80 solutions.Alterations in L-Histidine Transport in-Response to Aspirin- and Nimesulide-Induced Toxicity in Rat Intestine Using Everted Intestinal Sacs.The genotoxic and cytotoxic effects of nimesulide in the mouse bone marrow.Pharmacokinetic profile and in vitro selective cyclooxygenase-2 inhibition by nimesulide in the dog.Increased expression of cyclooxygenase-2 protein during rat hepatocarcinogenesis caused by a choline-deficient, L-amino acid-defined diet and chemopreventive efficacy of a specific inhibitor, nimesulide.Nimesulide-modified gum karaya solid mixtures: preparation, characterization, and formulation development.Genotoxicity of nimesulide in Wistar rats.Nimesulide, a COX-2 inhibitor, does not reduce lesion size or number in a nude mouse model of endometriosis.Preparation and evaluation of nimesulide-loaded ethylcellulose and methylcellulose nanoparticles and microparticles for oral delivery.Effect of pH and water-soluble polymers on the aqueous solubility of nimesulide in the absence and presence of beta-cyclodextrin derivatives.Detection of nimesulide metabolites in rat plasma and hepatic subcellular fractions by HPLC-UV/DAD and LC-MS/MS studies.[A heterogenous drug class. NSAID: classification and spectrum of action].Nimesulide/methyl β-cyclodextrin inclusion complexes: physicochemical characterization, solubility, dissolution, and biological studies.Analgesics and AntipyreticsA Simple, Rapid, and Validated LC Method for the Estimation of Nimesulide in Human Serum and Its Application in Bioavailability StudiesHPLC Determination of Nimesulide in Tablets by Electrochemical DetectionCometabolic Degradation of Anti-Inflammatory and Analgesic Pharmaceuticals by a Pentane Enrichment CultureNimesulide Based Novel Glycolamide Esters: Their Design, Synthesis, and Pharmacological Evaluation
P2860
Q21135231-4B621F5B-519C-4FB6-80A7-62CBE35CED23Q24646764-34EF4803-912D-47D1-AA9A-59BBD80430E9Q24805545-C8812BC9-CAF0-489E-B3BC-CA91821246D8Q33730618-B435CE1C-7F28-4791-8F7C-56DBD2D06ECCQ33758859-F4EF7021-7364-41B4-B0E0-35742724257CQ33948672-EE5554D0-E24E-42C6-B901-3C2F9EDA1604Q34571121-5491378A-0E76-42F2-B957-99D8068EE942Q35566464-F15FB94D-13E1-4BB2-85B6-28741B96615CQ37733317-C00F7DFD-9EBF-42E5-A87C-7B0976CB2DE7Q40039561-0915AD8C-BE23-4247-8020-913072D725DEQ41866090-F9B428D1-3809-4049-A671-4CC959C95DCDQ41990512-4052BCF2-0F80-4788-8FA0-AC51F32B8769Q42005726-399EA334-43C2-4EE2-AD62-2E6C62A4B079Q43215741-34677847-634A-4E94-A4C0-8DC5586D1BF3Q43508324-319DE77B-FF8C-45FA-B1D7-E45B44AE5C46Q43604445-CACF4419-06DA-4C6D-AC3F-0B8E56D639BFQ43901522-A3B829DD-9013-4179-8E26-0BFDB619A1ADQ44626152-3B19CCFE-6707-4BEA-8621-622663D691ACQ44938760-DF3A2EBB-BFED-45C2-99F7-0A61D04E6B02Q45165258-B01C3A31-F018-453F-A072-5490D8E5EC7CQ46040434-812814CF-FA39-4FF1-B4A7-50074B2370BDQ46289455-87FEF394-0E43-45D3-9C22-57D756FE66B2Q46595827-F1F7C355-57F7-4430-B00F-7D75061F4A71Q53923486-A5456D1E-18EC-4F1A-9F2B-5DE8CFA6651DQ54285104-E5610128-1EEA-4818-AA5A-52661D9E7B6EQ56113559-667EA3F8-5A1A-427E-9D18-F1AF7BF2DD6CQ58185545-33FB3217-0AA7-4B0D-971E-613BBE026194Q58290476-1396EC45-1C08-4B81-A51E-BAAE7A8DDEC3Q58852855-B39CD57C-055C-426B-B799-4DB8F623F9BEQ59010506-349BB947-3D03-42E0-9F6B-9CC10F6059CE
P2860
Nimesulide. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Nimesulide. An update of its p ...... ies, and therapeutic efficacy.
@en
type
label
Nimesulide. An update of its p ...... ies, and therapeutic efficacy.
@en
prefLabel
Nimesulide. An update of its p ...... ies, and therapeutic efficacy.
@en
P1433
P1476
Nimesulide. An update of its p ...... ies, and therapeutic efficacy.
@en
P2093
P304
P356
10.2165/00003495-199448030-00008
P577
1994-09-01T00:00:00Z
P6179
1024343394